---
title: Cancer Clinical Trials & Investigational Medicine Units
permalink: /platform-1/cancer-clinical-trials-and-investigational-medicine-units/
description: Cancer Clinical Trials & Investigational Medicine Units
variant: tiptap
---
<p>The Cancer Clinical Trials and Investigational Medicine Units platform
aims to drive impactful and innovative clinical research and elevate Singapore’s
position as a leading destination for conducting cancer clinical trials.
We offer unique solutions to support and streamline clinical trial conduct
by bringing together the expertise, capabilities and resources across the
three healthcare clusters in Singapore. Our platform works closely with
research and pharmaceutical/ biotechnology organisations in both the public
sector and industry with the common goal of facilitating access to innovative
treatments for cancer patients.</p>
<h3><strong>Our capabilities and initiatives</strong></h3>
<ul data-tight="true" class="tight">
<li>
<p>An established framework for collaborative multi-centre cancer research
with streamlined contracting and centralised workflows for facilitation
of multi-centre studies</p>
</li>
<li>
<p>Coordinate and promote translational cancer research collaborations for
and amongst different Large Collaborative Grant (LCG) programmes and cancer
groups</p>
</li>
<li>
<p>Founded a national Key Opinion Leader (KOL) network – the<strong> STCC Tumour Groups</strong> -
comprising of multidisciplinary experts from Singapore’s three healthcare
clusters aimed to:</p>
<ul data-tight="true" class="tight">
<li>
<p>Develop strategic cancer research agenda aligned with national needs.</p>
</li>
<li>
<p>Shape Singapore’s cancer research ecosystem through top priority trials
with high translational value.</p>
</li>
<li>
<p>Groups have been established in the following areas of cancer research:</p>
<ul data-tight="true" class="tight">
<li>
<p><strong>Breast Cancer</strong>
</p>
</li>
<li>
<p><strong>Thoracic Cancer and Head and Neck</strong>
</p>
</li>
<li>
<p><strong>Gastrointestinal (GI) Cancers</strong>
</p>
</li>
<li>
<p><strong>Genito-urinary (GU) Cancers</strong>
</p>
</li>
<li>
<p><strong>Sarcoma/Rare Malignancies (including central nervous system cancers)</strong>
</p>
</li>
<li>
<p><strong>Lymphoma</strong>
</p>
</li>
<li>
<p><strong><a href="https://www.scri.edu.sg/singapore-myeloma-tumour-group/about/" rel="noopener noreferrer nofollow" target="_blank">Myeloma</a></strong>
</p>
</li>
<li>
<p><strong>Leukemia</strong>
</p>
</li>
<li>
<p><strong><a href="https://www.scri.edu.sg/gcgs/about-gcgs/" rel="noopener noreferrer nofollow" target="_blank">Gynaecologic Cancer</a></strong>
</p>
</li>
<li>
<p><strong>Phase 1 and Clinical Pharmacology</strong>
</p>
</li>
<li>
<p><strong>Nucleic Acid Therapeutics and Cancer Vaccines</strong>
</p>
</li>
</ul>
</li>
</ul>
<p></p>
</li>
</ul>
<p>For feasibility requests or clinical trial enquiries, please send them
to&nbsp;<a href="mailto:mailbox@stcc.cris.sg?subject=STCC%20Cancer%20Clinical%20Trials%20and%20Investigational%20Medicine%20Units" rel="noopener noreferrer nofollow" target="_blank"><u>mailbox@stcc.cris.sg</u></a>.</p>
<p>F</p>